SecBot SecBot
SECBOTREPLAY Home › Report › ABT

ABT · A New Jersey federal district court granted Abbott Laboratories' motion…

ABBOTT LABORATORIES · COURT-RULING filed Mar 25, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 3/10

COURT-RULING filed Mar 25, 2026 at 20:00 ET

A New Jersey federal district court granted Abbott Laboratories' motion to dismiss a product liability lawsuit concerning its Trifecta GT heart valve. The court dismissed all three of plaintiff's common law claims (negligence, strict liability, failure to warn) without prejudice, holding they are subsumed by the New Jersey Products Liability Act (NJPLA), which provides the exclusive remedy. This is a procedural ruling that removes this single lawsuit's common-law claims; it does not adjudicate the merits, award damages, or set binding precedent, and the plaintiff has 30 days to amend.

  • Court granted Abbott's motion to dismiss the complaint under Rule 12(b)(6).
  • The three common-law claims (negligence, strict liability, failure to warn) were dismissed as subsumed by the New Jersey Products Liability Act (NJPLA).
  • Dismissal is without prejudice; plaintiff may file an amended complaint within 30 days.
  • The ruling involves a single individual plaintiff's product liability case, not a class action or multi-district litigation.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access